What is the MNPR stock price prediction for next 2 weeks?

According to our price prediction algorithm,Monopar Therapeutics Inc. (MNPR) price will be around $61.78 in the next 2 weeks. This means it will decrease by -12.891567963902997 from the last closing price. This prediction may vary from other time period filters for MNPR stock.

What can be the highest Possible price of MNPR stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, MNPR can achieve the highest price of $66.26 which is -6.569630429138251 lower than last closing price. This prediction may vary from other time period filters for MNPR stock.

What can be the lowest Possible price of MNPR stock in next 2 weeks?

As per the forecast and algorithmic analysis, MNPR stock price can be as low as $57.51 which is -18.911587371662424 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for MNPR stock.

Will MNPR stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that MNPR stock will lose-12.891567963902997 in the next 2 weeks. This prediction may vary from other time period filters for MNPR stock.

What is MNPR stock last closing price?

Last closing price of MNPR stock was $70.92.

What is MNPR stock price prediction?

MNPR stock price prediction means predicting the future closing prices of MNPR stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of MNPR stock in a certain time period.

How we predict MNPR stock future prices?

If you are searching for MNPR stock forecast, analysis or price prediction, then you might be wondering what Monopar Therapeutics Inc. (MNPR) will do in the future. Our MNPR price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This MNPR price prediction will likely answer most of your questions.

How frequent we update MNPR stock predictions?

We are updating the forecasts for the MNPR stock on daily basis.

Is using ML forecasting for MNPR stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for MNPR stock same for all the time periods?

No, the prediction for MNPR stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Monopar Therapeutics Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$70.92-5.99%Since 2 Weeks

Predicted Price$61.78-12.89%For 2 Weeks

Upper Predicted Price$66.26-6.57%For 2 Weeks

Lower Predicted Price$57.51-18.91%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of MNPR will decline by -12.89% over the next 2 Weeks and hit $61.78 by Monday, January 5, 2026. In that time frame, MNPR's share price is expected to range between $57.51 and $66.26.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Jan 5, 2026	57.51	61.78	66.26
Jan 2, 2026	59.02	63.23	67.67
Jan 1, 2026	59.29	63.23	67.04
Dec 31, 2025	58.66	62.81	66.91
Dec 30, 2025	58.67	62.81	66.93
Dec 29, 2025	61.17	65.41	69.41
Dec 26, 2025	62.88	66.86	70.87
Dec 25, 2025	62.97	66.87	70.88
Dec 24, 2025	62.19	66.45	70.46
Dec 23, 2025	61.97	66.45	70.48

MNPR shares fell -0.59% in Tuesday, December 23, 2025's trading session, dropping from a previous close of $70.92 to move at $70.50. The stock demonstrated notable intraday movement (see MNPR's key stats for a full breakdown), fluctuating between $70.15 and $74.33, a +5.96% trading range. While recent weeks have seen some volatility, MNPR has managed to secure a -7.76% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 172.04K shares changing hands, 346.14K fewer than the previous session. This amounted to $12.13M in total market activity.

Will MNPR Continue Its Downward Trend?

According to analyst ratings and projections for MNPR, Monopar Therapeutics Inc. shares are anticipated to decrease by -6.40%, potentially reaching $66.26 per share by January 5, 2026. Short-term technical indicators currently suggest a neutral sentiment for MNPR. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 15 positive trading days within the past 30 sessions. Based on the MNPR stock forecast, now is not the best time to buy MNPR stock because its current trading price is +14.12% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on MNPR covering social and institutional perspectives.

MNPR Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into MNPR's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 39.69% to 43.28%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 50.30%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 52.91%, maintains a neutral outlook for the long term. Insights into MNPR's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Monopar Therapeutics Short-Term Forecasts

MNPR Forecast For Next 5 Days

Our algorithm anticipates Monopar Therapeutics (MNPR) stock could hit $72.11 by Dec 30, 2025. This represents a +2.29% fall from today's price, following a -4.95% change over the past five days.

MNPR Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Monopar Therapeutics Inc. (MNPR) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $70.71, which would mean a +0.30% increase from the current price of $70.50. Projections for this period range from a high of $83.57 to a low of $55.80.

MNPR Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Monopar Therapeutics's price over the next three months point to a rise. MNPR stock is expected to peak at $86.93 on Mar 10, 2026 after potentially dipping to $58.78 on Jan 06, 2026. On average, MNPR is likely to trade around $73.76 in the coming 90 days.

Monopar Therapeutics Stock Forecast 2025

Based on our predictive models, Monopar Therapeutics (MNPR) is expected to trade between $61.38 and $75.49 throughout 2025. This would result in an average price of $68.61, potentially offering investors a -2.68% return from current levels.

Monopar Therapeutics Inc. Monthly Forecast 2025–2026

December 2025

According to our latest forecast models, Monopar Therapeutics Inc. (MNPR) is positioned to show a strong performance in December 2025. The price is predicted to move between $61.38 and $75.49, settling at an average of $68.61. This could translate to a -2.68% loss.

January 2026

Based on current market signals, Monopar Therapeutics Inc. is projected to trend january 2026. We forecast a trading range from $58.78 to $79.40, with a likely average price of $69.06. Investors could expect a potential return of -2.04%.

February 2026

Our predictive algorithms indicate Monopar Therapeutics Inc. stock may see a shift in February 2026. The expected range spans $65.16–$85.91, with an average target of $76.09. This represents a positive outlook and a possible gain of +7.93%.

March 2026

Analyzing established trends, Monopar Therapeutics Inc. looks set to move in March 2026. Projections place the stock between $70.81 and $86.93, averaging around $79.09. This suggests a +12.18% gain from current levels.

April 2026

Market indicators suggest Monopar Therapeutics Inc. could experience notable changes during April 2026. Prices could fluctuate within $70.79 to $87.64, with a midpoint forecast of $78.90. The stock might deliver a +11.91% gain.

May 2026

Forecasting for May 2026, models estimate that Monopar Therapeutics Inc. may undergo key fluctuations. If trends hold, the stock might trade between $68.87 and $88.19, averaging $78.85. This signals a positive trajectory with potential returns around +11.84%.

June 2026

According to our latest forecast models, Monopar Therapeutics Inc. (MNPR) is positioned to show a strong performance in June 2026. The price is predicted to move between $66.63 and $85.69, settling at an average of $76.36. This could translate to a +8.31% gain.

July 2026

Based on current market signals, Monopar Therapeutics Inc. is projected to trend july 2026. We forecast a trading range from $72.62 to $94.78, with a likely average price of $83.91. Investors could expect a potential return of +19.02%.

August 2026

Our predictive algorithms indicate Monopar Therapeutics Inc. stock may see a shift in August 2026. The expected range spans $77.72–$95.79, with an average target of $86.20. This represents a positive outlook and a possible gain of +22.27%.

September 2026

Analyzing established trends, Monopar Therapeutics Inc. looks set to move in September 2026. Projections place the stock between $77.86 and $95.29, averaging around $86.43. This suggests a +22.60% gain from current levels.

October 2026

Market indicators suggest Monopar Therapeutics Inc. could experience notable changes during October 2026. Prices could fluctuate within $74.25 to $103.76, with a midpoint forecast of $85.93. The stock might deliver a +21.89% gain.

November 2026

Forecasting for November 2026, models estimate that Monopar Therapeutics Inc. may undergo key fluctuations. If trends hold, the stock might trade between $73.52 and $106.00, averaging $84.98. This signals a positive trajectory with potential returns around +20.54%.

December 2026

According to our latest forecast models, Monopar Therapeutics Inc. (MNPR) is positioned to show a strong performance in December 2026. The price is predicted to move between $80.94 and $100.98, settling at an average of $90.68. This could translate to a +28.62% gain.

MNPR's history of dividends and stock splits also plays a role in long-term investor confidence.